IJCS | Volume 33, Nº1, January / February 2019

21 1. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis- prospective cohort study. Arch Intern Med. 2009;169(5):463-73. 2. Baddour LM, WilsonWR, BayerAS, Fowler VG Jr, Tleyjeh IM, RybakMJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-86. 3. Chu VH, Cabell CH, Benjamin DK Jr, Kuniholm EF, Fowler VG Jr, Engemann J, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109(14):1745-9. 4. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology(ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. 5. Iser BPM, Stopa SR, Chueiri PS, Szwarcwald CL, Malta DC, Monteiro HOC, et al. Self-reported diabetes prevalence in Brazil: results from National Health Survey 2013. Epidemiol Serv Saúde. 2015;24(2):305-14. 6. Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F, et al. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis. 2010;19(3):312-20. 7. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med.1999;341(25):1906-12. 8. Movahed MR, Hashemzadeh M, Jamal MM. Increased prevalence of infective endocarditis in patients with type II diabetes mellitus. J Diabetes Complications. 2007;21(6):403-6. 9. Moreno R, Zamorano J, Almería C, Villate A, Rodrigo JL, Herrera D, et al. Influence of diabetes mellitus on short- and long-term outcome in patients with active infective endocarditis. J Heart Valve Dis. 2002;11(5):651-9. 10. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88(1):53-60. 11. Olmos C, Vilacosta I, Pozo E, Fernández C, Sarriá C, López J, et al. Prognostic implications of diabetes in patients with left-sided endocarditis: findings from a large cohort study. Medicine (Baltimore). 2014;93(2):114-9. 12. Duval X, Alla F, Doco-Lecompte T, Le Moing V, Delahaye F, Mainardi JL, et al. Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality. Eur Heart J. 2007;28(1):59-64. 13. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96(3):200-9. 14. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposedmodifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-8. 15. Hutin Y, Hauri A, Chiarello L, Catlin M, Stilwell B, Ghebrehiwet T, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular injections. Bull World Health Organ. 2003;81(7):491-500. 16. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart. 2003;89(5):577-81. 17. Camata DG. Local complications in the skin related to the administration of insulin. Rev Lat Am Enfermagem. 2003;11(1):119-22. 18. Kahara T, Kawara S, ShimizuA, HisadaA, Noto Y, Kida H. Subcutaneous hematoma due to frequent insulin injections in a single site. Intern Med. 2004;43(2):148-9. 19. Fleming DR, Jacober SJ, Vandenberg MA, Fitzgerald JT, Grunberger G. The safety of injecting insulin through clothing. Diabetes Care. 1997;20(3):244-7. 20. Tuazon CU, Perez A, Kishaba T, Sheagren JN. Staphylococcus aureus among insulin-injecting diabetic patients: an increased carrier rate. JAMA. 1975;231(12):1272. 21. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30(3):579-81. 22. Lipsky BA, Kollef MH, Miller LG, Sun X, Johannes RS, Tabak YP. Predicting bacteremia among patients hospitalized for skin and skin- structure infections: derivation and validation of a risk score. Infect Control Hosp Epidemiol, 2010;31(8):828-37. 23. Monami M, Mannucci E, Masotti G. Finger sepsis in two poorly controlled diabetic patients with reuse of lancets. Diabetes Care. 2002;25(6):1103. 24. Ryan EA, Miller J, Skyler JS. Finger sepsis: possible complication of self monitoring of blood glucose concentrations. Br Med J (Clin Res Ed). 1983;286(6378):1614-5. 25. Suzuki Y, Atsumi Y, Matsnoka K. Finger infection resulting from self- monitoring of blood glucose and a new aid for reducing risk. Diabetes Care. 1998;21(8):1373-4. 26. Hochman B, Nahas FX, Oliveira Filho RS, Ferreira LM. Research designs. Acta Cir Bras. 2005;20( suppl 2):2-9. 27. Miot HA. Sample size in clinical and experimental trials. J Vasc Bras. 2011;10(4):275-8. 28. Yang F, Zhang B, Yu J, Lingyun Shao, Pu Zhou, Liping Zhu, et al. Epidemiology and the prognosis of healthcare-associated infective endocarditis in China: the significance of non-nosocomial acquisition. Emerg Microbes Infect. 2015;4(7):e38. 29. Nunes MC, Gelape CL, Ferrari TC. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis. 2010;14(5):e394-8. 30. Ruiz Jr E, Schirmbeck T, Figueiredo LTM. A study of infective endocarditis in RibeirãoPreto, SP - Brazil. Analysis of cases occurring between 1992 and 1997. Arq Bras Cardiol. 2000;74(3):217-31. 31. WangA. Diabetes mellitus and insulin therapy in infective endocarditis. Eur Heart J. 2007;28(1):3-4. 32. Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155(15):1641-8. 33. Hecht S, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes.Ann Internal Med. 1992;117(7):560-6. 34. Dressler FA, Roberts WC. Infective endocarditis in opiate addicts: analysis of 80 cases studied at necropsy. Am J Cardiol. 1989;63(17):1240-57. References Lott Bezerra et al. Insulin use and infective endocarditis Int J Cardiovasc Sci. 2020;33(1):14-21 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License